|
ZRANB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48334686148155E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.53430609831184E-12 |
| Normal-vs-Stage2 |
1.1340999994669E-07 |
| Normal-vs-Stage3 |
1.30410000021008E-07 |
| Normal-vs-Stage4 |
1.837600E-03 |
| Stage1-vs-Stage2 |
9.395000E-01 |
| Stage1-vs-Stage3 |
5.255000E-01 |
| Stage1-vs-Stage4 |
7.226800E-01 |
| Stage2-vs-Stage3 |
5.528600E-01 |
| Stage2-vs-Stage4 |
6.710600E-01 |
| Stage3-vs-Stage4 |
9.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86006765545699E-12 |
| Normal-vs-AfricanAmerican |
8.25770000156822E-08 |
| Normal-vs-Asian |
4.09649999999484E-06 |
| Caucasian-vs-AfricanAmerican |
2.067400E-01 |
| Caucasian-vs-Asian |
4.691200E-01 |
| AfricanAmerican-vs-Asian |
2.448400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.07531777821168E-14 |
| Normal-vs-Female |
1.78886999999683E-05 |
| Male-vs-Female |
5.284700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.71660000050744E-07 |
| Normal-vs-Extreme_Weight |
1.88737914186277E-14 |
| Normal-vs-Obese |
1.22500000143688E-08 |
| Normal-vs-Extreme_Obese |
5.20509999990537E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.885400E-01 |
| Normal_Weight-vs-Obese |
3.195400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.627000E-01 |
| Extreme_Weight-vs-Obese |
1.463600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.888800E-01 |
| Obese-vs-Extreme_Obese |
1.935990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.154100E-04 |
| Normal-vs-Age(41-60Yrs) |
9.88359949438689E-10 |
| Normal-vs-Age(61-80Yrs) |
3.50830475781549E-14 |
| Normal-vs-Age(81-100Yrs) |
6.34039999999336E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.175400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.189580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.677600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.041600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.959900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.594600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.23119309086906E-12 |
| Normal-VS-Type2 PRCC |
1.65267799445701E-12 |
| Normal-VS-KIRP CIMP |
1.682410E-02 |
| Normal-VS-Unclassified PRCC |
3.356500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.809800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.105950E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.100000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.550320E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.950400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.579400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1094237467878E-15 |
| Normal-vs-N1 |
1.656190E-03 |
| Normal-vs-N2 |
3.845900E-04 |
| N0-vs-N1 |
2.916300E-02 |
| N0-vs-N2 |
6.573400E-01 |
| N1-vs-N2 |
5.021600E-01 |
|
|
